Pandemic hurts sales, profit for Pfizer amid restructuring
FAIRLESS HILLS, Pa. (AP) — Pfizer Inc. reported a 32% plunge in second-quarter profit, mainly due to the global coronavirus pandemic limiting marketing of and new prescriptions for its medicines, even as the drugmaker races to develop a vaccine.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
